Merck
(NYSE: MRK)

 

NOVARTIS
(NYSE: NVS)




MicroDose values quality partnerships with the world's leading pharmaceutical and biotechnology companies as a key driver for its success and growth. MicroDose's collaborators include many of the top pharmaceutical companies in the world, as well as biotechnology companies developing the products of the future. Collaborating with strong partners will enable the rapid and successful commercialization of our proprietary drug delivery technologies and products.Not all of our partnerships can be disclosed in the public domain, but above are some of MicroDose's current partners (click on the logo to view the press release).   In addition to the above publicly disclosed partnerships, MicroDose has evaluation collaborations ongoing with four undisclosed major pharmaceutical partners in the respiratory fields of asthma and COPD. 






Please visit our User Agreement. Your continued use of this site will automatically constitute your agreement to be bound by all the terms and conditions of the User Agreement.

©2004 MicroDose Technologies, Inc.